As the largest independent provider of acute surgical services, BMI Healthcare has been at the forefront of the drive to improve clinical and non-clinical service standards across the independent sector.
We aim to provide the highest standards in all aspects of patient care. This includes ensuring unequalled attention to hygiene and involving patients in the process to minimise any risks of infection.
This enables us to maintain our excellent record for cases and rates of MRSA, Clostridium Difficile and wound infection. Detailed information is provided on each of these topics.
MRSA Screening
BMI Healthcare is committed to the provision of high quality care to ensure the best possible outcomes for our patients. This includes robust infection prevention and control activities to minimise the risk of any of our patients acquiring any healthcare associated infection.
BMI Healthcare’s routine practice in relation to MRSA screening is to take a targeted and focused approach and screen selectively in light of the clinical needs of each patient. The availability of dedicated nursing teams, compliance with appropriate precautions, and single room accommodation, which can be used for isolation rooms if required, enable us to adopt this approach.
All NHS patients admitted under contracted agreement are screened for MRSA in line with the latest Department of Health (DH) Guidance.
An eradication programme is offered to those patients whose screening results indicate that they are colonised with MRSA.
All results are monitored and evaluated and will guide further policy development. Currently BMI Healthcare is able to report that they have had no MRSA bacteraemias in the past 12 months, and only isolated superficial MRSA wound infections.
A copy of our policy on the management of Methicillin Resistant Staphylococcus Aureus (MRSA) is available here.
